Incontinence News and Research

Latest Incontinence News and Research

Antares Pharma second-quarter total revenue increases 78% to $3.1 million

Antares Pharma, Inc. today reported financial and operating results for the second quarter ended June 30, 2010.

13 Aug 2010

Winner Medical third-quarter net sales increase 27.0% to $30.9 million

Winner Medical Group Inc., a leading manufacturer of medical dressings, medical disposables and non-woven PurCotton materials for the medical and consumer products industries in China, today reported that third quarter fiscal year 2010 revenue year-on-year increased 27.0%, to $30.9 million, net income increased 10.1% to $3.4 million and a sales of PurCotton products year-on-year increased 114.0%, to $2.6 million.

11 Aug 2010

AMS AdVance XP sling for male stress urinary incontinence receives CE Mark

American Medical Systems, a leading provider of world-class devices and therapies for both male and female pelvic health, announced today the company received CE Mark for AdVance XP. The device is the latest generation of AMS' AdVance sling, a minimally invasive implant for the treatment of male stress urinary incontinence (SUI).

9 Aug 2010

American Medical Systems second-quarter net income increases 22.0% to $20.6M

American Medical Systems Holdings, Inc. reported sales of $136.4 million for the second quarter of 2010, a 7.9 percent increase over sales of $126.4 million in the comparable quarter of 2009. Adjusting for the negative impact of $1.4 million due to fluctuations in foreign exchange rates since the time the second quarter guidance was issued; revenue would have achieved the upper end of the guidance range.

4 Aug 2010

New surgical technique to maximize preservation of periprostatic anatomy

Stress urinary incontinence is one of the most feared complications of radical prostatectomy. The weighted mean continence rate immediately after catheter removal following robot-assisted laparoscopic radical prostatectomy (RALP) is 25.7%. Evidently, early recovery of urinary continence remains a challenge to be overcome. The Surgery in Motion section of the September issue of European Urology describes the surgical steps of pubovesical complex (PVC)-sparing RALP and presents the preliminary results of the technique.

3 Aug 2010

Disparities in cardiovascular disease risk linked to socioeconomic differences between races: Study

A new UCLA study suggests that disparities in cardiovascular disease risk in the United States are due less to race or ethnicity than to socioeconomic status.

2 Aug 2010

Rochester Medical third-quarter sales increase 15% to $10.24 million

Rochester Medical Corporation today announced operating results for its third quarter ended June 30, 2010.

30 Jul 2010

NMF raises $30,000 in 30 days to help women have gynecologic surgery

Natividad Medical Foundation President & CEO Linda Ford announced NMF has raised $30,000 in 30 days – enough for about 12 women to have the gynecologic surgery they so desperately need. The announcement is part of the launch of The Onyx Fund for Women – named in honor of a Natividad Medical Center patient named Onix who inspired a hospital's doctors and a philanthropic fund.

29 Jul 2010

Nymox provides update on NX-1207 Phase 3 program for benign prostatic hyperplasia

Nymox Pharmaceutical Corporation provided an update today on the Company's Phase 3 program for NX-1207, Nymox's investigational drug for benign prostatic hyperplasia (BPH). The Safety Monitoring Committee meeting of July 22, 2010 for the Phase 3 U.S. pivotal trials of NX-1207 was favorable and indicated no significant safety concerns for the trials to date. Patient recruitment and trial activities for pivotal U.S. studies NX02-0017 and NX02-0018 are proceeding at over 70 well-known urology investigative sites throughout the U.S.

29 Jul 2010

Antares Pharma reports positive results from Anturol Gel Phase 3 study in overactive bladder patients

Antares Pharma, Inc. announced today positive results from its Phase 3 study of Anturol Gel in patients with overactive bladder. The study met its primary endpoint of a statistically significant reduction in urinary incontinence episodes for both doses studied.

28 Jul 2010

Female sexual dysfunction can affect quality of life: Research

Almost two-thirds of females attending a general urology practice reported that they suffered from sexual dysfunction, according to a paper in the August issue of BJUI. Dysfunction rose with age in all categories except orgasm, with more than half of women aged from 18 to 30 reporting orgasm problems, significantly higher than women aged 31 to 54.

27 Jul 2010

Underwriters exercise over-allotment option in Uroplasty's common stock public offering

Uroplasty, Inc. announced today that the underwriters for the recently announced public offering of Uroplasty common stock have exercised in full their over-allotment option to purchase an additional 600,000 shares of the Company's common stock. The 4,600,000 shares of Uroplasty common stock in the offering, including the 600,000 shares subject to the over-allotment option, are being sold at a price to the public of $3.50 per share.

26 Jul 2010

Uroplasty prices underwritten public offering of common stock

Uroplasty, Inc. announced today that its underwritten public offering of 4 million shares of its common stock was priced at $3.50 per share. Uroplasty has granted the underwriters of the offering an option to purchase up to an additional 600,000 shares of common stock within the next 30 days, solely to cover over-allotments, if any. All of the shares in the offering are being offered by Uroplasty. Uroplasty expects the offering to close on July 27, 2010, subject to customary closing conditions.

23 Jul 2010

Uroplasty intends to offer shares of common stock in underwritten public offering

Uroplasty, Inc. announced today that it intends, subject to market and other conditions, to offer shares of its common stock in an underwritten public offering. Uroplasty also intends to grant the underwriters of the offering an option to purchase additional shares of common stock to cover over-allotments, if any.

22 Jul 2010

SWHR hosts briefing on urinary incontinence, overactive bladder

The Society for Women's Health Research (SWHR) hosted the Capitol Hill briefing, The Bladder Matters: What Women Need to Know on Thursday, July 15, which highlighted startling statistics and an insightful patient perspective. Featuring noted researchers, physicians, Hill staff, and a UI-afflicted patient, the aim of this widely attended briefing was to detail current research on urinary incontinence (UI) and present future outlooks.

22 Jul 2010

Benefits of drug L-methionine for neurogenic bladder disorders unclear

It is unclear whether patients with neurogenic bladder disorders benefit from the drug L-methionine. The only study currently available provides neither proof of benefit nor proof of harm. This is the result of a report published by the German Institute for Quality and Efficiency in Health Care (IQWiG) on 12 July 2010.

20 Jul 2010

EndoStim raises $6M in Series B equity financing round

EndoStim, Inc., a medical device company developing minimally-invasive interventional therapies to treat gastrointestinal and urological neuro-muscular disorders, today announced it has raised $6 million in Series B equity financing. Santé Ventures, a life science venture capital firm, led the round and was joined by the Prolog Ventures, Vectis Healthcare & Life Sciences Fund II and returning angel investors.

19 Jul 2010

Percentage of nursing home residents kept physically restrained declined to 5% in 2007: AHRQ

The number of residents at nursing homes who were kept physically restrained dropped by more than half from 1999 to 2007, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

17 Jul 2010

AMS reports positive results from clinical trial of MiniArc Single-Incision Sling System for SUI

American Medical Systems® (AMS), a leading provider of world-class devices and therapies for both male and female pelvic health, today announced results of a prospective, multi-center study on their market leading MiniArc Single-Incision Sling System for female stress urinary incontinence (SUI). The study concludes that MiniArc efficacy rates for negative cough stress test (CST) and 1-hr Pad Weight Test (PWT) at 12 months were 90.6 percent and 84.5 percent, respectively.

15 Jul 2010

Diet and exercise can reduce severity of hot flashes in overweight, obese women

A new study shows that overweight and obese women who suffer from hot flashes can reduce the severity of their hot flashes if they lose weight through diet or exercise.

14 Jul 2010

Incontinence News and Research

Latest Incontinence News and Research

Antares Pharma second-quarter total revenue increases 78% to $3.1 million

Winner Medical third-quarter net sales increase 27.0% to $30.9 million

AMS AdVance XP sling for male stress urinary incontinence receives CE Mark

American Medical Systems second-quarter net income increases 22.0% to $20.6M

New surgical technique to maximize preservation of periprostatic anatomy

Disparities in cardiovascular disease risk linked to socioeconomic differences between races: Study

Rochester Medical third-quarter sales increase 15% to $10.24 million

NMF raises $30,000 in 30 days to help women have gynecologic surgery

Nymox provides update on NX-1207 Phase 3 program for benign prostatic hyperplasia

Antares Pharma reports positive results from Anturol Gel Phase 3 study in overactive bladder patients

Female sexual dysfunction can affect quality of life: Research

Underwriters exercise over-allotment option in Uroplasty's common stock public offering

Uroplasty prices underwritten public offering of common stock

Uroplasty intends to offer shares of common stock in underwritten public offering

SWHR hosts briefing on urinary incontinence, overactive bladder

Benefits of drug L-methionine for neurogenic bladder disorders unclear

EndoStim raises $6M in Series B equity financing round

Percentage of nursing home residents kept physically restrained declined to 5% in 2007: AHRQ

AMS reports positive results from clinical trial of MiniArc Single-Incision Sling System for SUI

Diet and exercise can reduce severity of hot flashes in overweight, obese women

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Incontinence News and Research

Latest Incontinence News and Research

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Newsletters you may be interested in